Trial intelligence / Profile preview

Levetiracetam Effects on Sleep Architecture in Epilepsy

NCT00245713Phase 4Completed

Sponsor
UCB
Start
Mar 2003
Primary completion
Nov 2004
Modality
Small Molecules
01

Overview

Phase 4, randomised, double-blind trial in epilepsy comparing Levetiracetam with Placebo (2 arms). Primary endpoints: Percent Rapid Eye Movement Sleep, Percent Slow Wave Sleep (Stages 3 and 4) and 1 more. Started Mar 2003; status: completed.

02

Drugs

levetiracetam
03

Conditions

epilepsy

Beyond the preview

Go deeper on NCT00245713.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00245713.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call